Cyclobutanes in Small-Molecule Drug Candidates

被引:116
|
作者
van der Kolk, Marnix R. [1 ]
Janssen, Mathilde A. C. H. [1 ]
Rutjes, Floris P. J. T. [1 ]
Blanco-Ania, Daniel [1 ]
机构
[1] Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6526 AJ Nijmegen, Netherlands
基金
荷兰研究理事会;
关键词
Cyclobutanes; strained carbocycles; conformational restriction; pharmacophores; isosteres; HISTAMINE H-3 RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; APOLIPOPROTEIN-E; GLUCOKINASE ACTIVATORS; BIOLOGICAL EVALUATION; HISTONE MODIFICATIONS; SELECTIVE INHIBITORS; INDAZOLE DERIVATIVES; STRUCTURAL BASIS; POTENTIAL ROLE;
D O I
10.1002/cmdc.202200020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclobutanes are increasingly used in medicinal chemistry in the search for relevant biological properties. Important characteristics of the cyclobutane ring include its unique puckered structure, longer C-C bond lengths, increased C-C pi-character and relative chemical inertness for a highly strained carbocycle. This review will focus on contributions of cyclobutane rings in drug candidates to arrive at favorable properties. Cyclobutanes have been employed for improving multiple factors such as preventing cis/trans-isomerization by replacing alkenes, replacing larger cyclic systems, increasing metabolic stability, directing key pharmacophore groups, inducing conformational restriction, reducing planarity, as aryl isostere and filling hydrophobic pockets.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Direct small-molecule kinase activation: Novel approaches for a new era of drug discovery
    Simpson, Graham L.
    Hughes, Jennifer A.
    Washio, Yoshiaki
    Bertrand, Sophie M.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (05) : 585 - 596
  • [2] New small-molecule drug design strategies for fighting resistant influenza A
    Shen, Zuyuan
    Lou, Kaiyan
    Wang, Wei
    ACTA PHARMACEUTICA SINICA B, 2015, 5 (05) : 419 - 430
  • [3] The ribosome as a small-molecule sensor
    Bhattacharya, Arunima
    Renault, Thibaud
    Innis, C. Axel
    CURRENT OPINION IN MICROBIOLOGY, 2024, 77
  • [4] Small-Molecule Kinase Downregulators
    Jones, Lyn H.
    CELL CHEMICAL BIOLOGY, 2018, 25 (01): : 30 - 35
  • [5] New Small-molecule Analgesics
    Laev, S. Sergey
    Salakhutdinov, F. Nariman
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (30) : 6234 - 6273
  • [6] Drug screening approaches for small-molecule compounds in cancer-targeted therapy
    Zhao, Yelin
    Yuan, Chenyu
    Shi, Yuchen
    Liu, Xiaohong
    Luo, Liaoxin
    Zhang, Li
    Pesic, Milica
    Yao, Hongjuan
    Li, Liang
    JOURNAL OF DRUG TARGETING, 2025, 33 (03) : 368 - 383
  • [7] Small-molecule inhibitors of carboxylesterase Notum
    Zhao, Yuguang
    Jolly, Sarah
    Benvegnu, Stefano
    Jones, E. Yvonne
    Fish, Paul, V
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (11) : 1001 - 1015
  • [8] Allosteric small-molecule kinase inhibitors
    Wu, Peng
    Clausen, Mads H.
    Nielsen, Thomas E.
    PHARMACOLOGY & THERAPEUTICS, 2015, 156 : 59 - 68
  • [9] Small-molecule modulation of Ras signaling
    Spiegel, Jochen
    Cromm, Philipp M.
    Zimmermann, Gunther
    Grossmann, Tom N.
    Waldmann, Herbert
    NATURE CHEMICAL BIOLOGY, 2014, 10 (08) : 613 - 622
  • [10] Small-Molecule Screening for Genetic Diseases
    Markossian, Sarine
    Ang, Kenny K.
    Wilson, Christopher G.
    Arkin, Michelle R.
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19, 2018, 19 : 263 - 288